M. Tarek Al-Assi

1.8k total citations
12 papers, 566 citations indexed

About

M. Tarek Al-Assi is a scholar working on Surgery, Small Animals and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Tarek Al-Assi has authored 12 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 5 papers in Small Animals and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Tarek Al-Assi's work include Helicobacter pylori-related gastroenterology studies (10 papers), Veterinary medicine and infectious diseases (5 papers) and Gastric Cancer Management and Outcomes (4 papers). M. Tarek Al-Assi is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (10 papers), Veterinary medicine and infectious diseases (5 papers) and Gastric Cancer Management and Outcomes (4 papers). M. Tarek Al-Assi collaborates with scholars based in United States, Italy and Canada. M. Tarek Al-Assi's co-authors include David Y. Graham, Robert M. Genta, Tuomo J. Karttunen, Hala El‐Zimaity, Hoda M. Malaty, Rhonda A. Cole, David P. Graham, Robert M. Genta, H. M. T. EL‐ZIMAITY and Mahmoud M. Yousfi and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

M. Tarek Al-Assi

12 papers receiving 543 citations

Peers

M. Tarek Al-Assi
E. Sweeney Ireland
Laura L. George Australia
Reo Sato Japan
P A Gummett United Kingdom
S Brandl Australia
L. Zeijlon Sweden
E. Sweeney Ireland
M. Tarek Al-Assi
Citations per year, relative to M. Tarek Al-Assi M. Tarek Al-Assi (= 1×) peers E. Sweeney

Countries citing papers authored by M. Tarek Al-Assi

Since Specialization
Citations

This map shows the geographic impact of M. Tarek Al-Assi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Tarek Al-Assi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Tarek Al-Assi more than expected).

Fields of papers citing papers by M. Tarek Al-Assi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Tarek Al-Assi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Tarek Al-Assi. The network helps show where M. Tarek Al-Assi may publish in the future.

Co-authorship network of co-authors of M. Tarek Al-Assi

This figure shows the co-authorship network connecting the top 25 collaborators of M. Tarek Al-Assi. A scholar is included among the top collaborators of M. Tarek Al-Assi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Tarek Al-Assi. M. Tarek Al-Assi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Hart, Phil A., Raj J. Shah, José Nieto, et al.. (2023). A Randomized Controlled Phase 2 Dose-Finding Trial to Evaluate the Efficacy and Safety of Camostat in the Treatment of Painful Chronic Pancreatitis: The TACTIC Study. Gastroenterology. 166(4). 658–666.e6. 9 indexed citations
2.
Nelson, David R., K.V. Kowdley, M. Tarek Al-Assi, et al.. (2013). 6 ALL ORAL THERAPY WITH SOFOSBUVIR + RIBAVIRIN FOR 12 OR 16 WEEKS IN TREATMENT EXPERIENCED GT2/3 HCV-INFECTED PATIENTS: RESULTS OF THE PHASE 3 FUSION TRIAL. Journal of Hepatology. 58. S3–S4. 7 indexed citations
3.
Al-Assi, M. Tarek, Robert M. Genta, Tuomo J. Karttunen, & David Y. Graham. (1996). Ulcer Site and Complications: Relation to Helicobacter pylori Infection and NSAID Use. Endoscopy. 28(2). 229–233. 41 indexed citations
4.
El‐Zimaity, Hala, David Y. Graham, M. Tarek Al-Assi, et al.. (1996). Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Human Pathology. 27(1). 35–41. 195 indexed citations
5.
Al-Assi, M. Tarek, Rhonda A. Cole, Tuomo J. Karttunen, et al.. (1995). La Bible d'Alexandrie. LXX (Book). The Journal of Theological Studies. 90(1). 1411–195. 16 indexed citations
6.
Yousfi, Mahmoud M., H. M. T. EL‐ZIMAITY, M. Tarek Al-Assi, et al.. (1995). Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics. 9(2). 209–212. 76 indexed citations
7.
Malaty, Hoda M., H. M. T. EL‐ZIMAITY, Robert M. Genta, et al.. (1995). Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection. Gastroenterology. 108(4). A104–A104. 42 indexed citations
8.
Al-Assi, M. Tarek, Robert M. Genta, Tuomo J. Karttunen, Rhonda A. Cole, & David Y. Graham. (1995). Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth.. PubMed. 90(3). 403–5. 25 indexed citations
9.
El‐Zimaity, Hala, M. Tarek Al-Assi, Robert M. Genta, & David Y. Graham. (1995). Confirmation of successful therapy of Helicobacter pylori infection: number and site of biopsies or a rapid urease test.. PubMed. 90(11). 1962–4. 73 indexed citations
10.
Al-Assi, M. Tarek, Robert M. Genta, Tuomo J. Karttunen, & David Y. Graham. (1994). Clarithromycin‐amoxycillin therapy for Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics. 8(4). 453–456. 30 indexed citations
11.
Al-Assi, M. Tarek, Robert M. Genta, & David Y. Graham. (1994). Short Report: omeprazole‐tetracycline combinations are inadequate as therapy for Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics. 8(2). 259–262. 16 indexed citations
12.
Al-Assi, M. Tarek, Francisco C. Ramirez, Ginger M. Lew, Robert M. Genta, & D.Y. Graham. (1994). Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.. PubMed. 89(8). 1203–5. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026